4//SEC Filing
German Christopher Paul 4
Accession 0001104659-25-067428
CIK 0001649904other
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 4:30 PM ET
Size
14.6 KB
Accession
0001104659-25-067428
Insider Transaction Report
Form 4
German Christopher Paul
Corporate Controller & CAO
Transactions
- Sale
Common Stock
2025-07-09$85.00/sh−1,850$157,250→ 922 total - Exercise/Conversion
Stock Options (Right to Buy)
2025-07-09−850→ 4,550 totalExercise: $49.23Exp: 2034-02-15→ Common Stock (850 underlying) - Exercise/Conversion
Common Stock
2025-07-09$17.97/sh+2,000$35,940→ 3,889 total - Exercise/Conversion
Stock Options (Right to Buy)
2025-07-09−2,000→ 6,231 totalExercise: $17.97Exp: 2033-04-03→ Common Stock (2,000 underlying) - Exercise/Conversion
Common Stock
2025-07-09$49.23/sh+850$41,846→ 4,739 total - Sale
Common Stock
2025-07-09$76.75/sh−1,967$150,967→ 2,772 total
Footnotes (3)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2025.
- [F2]The stock options were granted on April 4, 2023. The options vest and become exercisable as to 25% of the total shares on March 20, 2024 and, thereafter, as to the remaining 75% of the total shares in twelve equal quarterly installments of 6.25% beginning June 20, 2024 and ending March 20, 2027, subject to the Reporting Person's continued service on each such vesting date.
- [F3]The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001260835
Filing Metadata
- Form type
- 4
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 4:30 PM ET
- Size
- 14.6 KB